Enjoy 20% off your first order · use code Free shipping on orders $100+ · free 2-Day $175+Ships today when you order before 3 PM ET

Purity & COAsNovember 6, 202615 min readCodex Research Team

HPLC vs Mass Spectrometry for Peptides: Purity vs Identity

Explore products
CR
Codex Research TeamPublished November 6, 2026

15 min read15 cited sources15 FAQs

HPLC and mass spectrometry answer two different questions about a research peptide: how much of the material is the target, and whether the target is the right molecule. This guide explains how each method works, what each one cannot see, and why a credible COA reports both.

Key takeaways

  • HPLC answers "what percentage of the sample is the target?" by separating the sample and measuring the main peak as a share of all peaks. Mass spectrometry answers "is it the right molecule?" by measuring molecular mass.
  • Neither method is enough on its own. A wrong peptide can still give one clean HPLC peak, and a correct mass says nothing about how much impurity is present.
  • HPLC purity is an area ratio, not an amount. It does not see water, salts or counter-ions, which is why purity and peptide content are reported separately.
  • Mass spectrometry cannot tell apart molecules with identical mass, such as leucine and isoleucine or D- and L-amino acids, so chromatography and tandem MS fill those gaps.
  • The strongest reports name the method for each result, show the chromatogram and mass spectrum, and come from an independent lab testing the same lot you received.
Important

Research use only. This guide explains how laboratory analytical methods are used to test research materials. It does not describe human or animal use. Codex Research compounds are not approved by the FDA and are sold for in-vitro laboratory research only.

Quick answer

HPLC and mass spectrometry answer two different questions. Reversed-phase high-performance liquid chromatography (RP-HPLC) separates a sample into its components and reports how much of what it detects is the main peptide, which is the purity figure on a COA. Mass spectrometry (MS, usually coupled to chromatography as LC-MS) measures molecular mass, which confirms identity: that the main peptide is the molecule it is supposed to be.

Neither method is complete on its own. A wrong peptide can produce one clean HPLC peak, and a correct mass says nothing about how many impurities sit alongside it. That is why a credible peptide certificate of analysis reports both.

The two questions every peptide test has to answer

Every lot of a synthetic peptide has to clear two hurdles before its results mean anything in a laboratory:

  1. Is it the right molecule? A synthesis can produce the wrong sequence, a sequence with a substituted residue, or a different compound altogether.
  2. How much of the material is that molecule? Even a correct synthesis leaves related impurities, such as chains missing an amino acid, oxidized residues or incompletely removed protecting groups [12].
Question Method that answers it What appears on a COA
Is it the right molecule? Mass spectrometry (LC-MS, ESI-MS or MALDI-TOF) Identity: measured mass vs theoretical mass, "Conforms"
How much of it is the target? Reversed-phase HPLC with UV detection Purity: main-peak area %, e.g. 99.23%
How many milligrams are present? Quantitative HPLC against a standard, amino acid analysis or nitrogen content Potency / assay / net peptide content
Is anything else in there? Endotoxin, sterility, microbial and residual tests Contaminant results against limits

This guide covers the first two rows, because they are the ones most often confused.

How HPLC works, step by step

High-performance liquid chromatography pushes a liquid sample through a narrow column packed with tiny porous particles. Different molecules travel through that column at different speeds, so they leave it at different times and can be measured one by one.

For peptides, the standard mode is reversed-phase chromatography [1]:

  • The column is packed with silica particles bonded to long hydrocarbon chains, most often C18. That surface is hydrophobic.
  • The mobile phase starts mostly water and gradually shifts toward an organic solvent, usually acetonitrile, over the run. This is called a gradient.
  • An acid modifier, typically 0.1% trifluoroacetic acid (TFA), is added to both solvents. It pairs with the charged groups on the peptide and sharpens the peaks.
  • Separation happens because each peptide sticks to the column according to its overall hydrophobicity. More hydrophobic peptides need more organic solvent to be released, so they elute later.

The contribution of individual amino acids to that retention has been measured systematically: researchers have derived hydrophobicity coefficients for each side chain from the retention of model peptides, which is why even a single-residue change can move a peak [2].

What the detector sees

As components leave the column they pass through a UV detector, usually set between 210 and 220 nm. At that wavelength the peptide bond itself absorbs light, so essentially every peptide-related component, target and impurity alike, produces a signal. The detector records a chromatogram: a trace of signal over time, with one peak for each separated component.

How the purity number is calculated

Purity is calculated by area normalization:

Purity (%) = area of the main peak ÷ total area of all integrated peptide peaks × 100

So a lot reported at 99.23% purity means the main peak accounts for 99.23% of the total peak area the detector recorded, and the remaining 0.77% is spread across related impurities.

Inside a typical peptide purity method

Every HPLC purity result comes from a specific set of conditions. Labs choose and validate their own, but most peptide purity methods look broadly like this [1]:

Parameter Typical choice Why it matters
Column C18 reversed-phase, 100–300 Å pores, 1.7–5 µm particles Wider pores suit larger peptides; smaller particles give sharper peaks
Mobile phase A Water with 0.1% TFA Aqueous starting solvent; TFA pairs with basic residues
Mobile phase B Acetonitrile with 0.1% TFA Organic solvent that releases peptides from the column
Gradient Slow rise in B over 20–60 minutes Shallower gradients separate closely related impurities better
Column temperature Often 25–60 °C Affects retention and peak shape
Detection UV at 210–220 nm The peptide bond absorbs here, so impurities are seen too
Injection A measured volume of dissolved sample Must stay within the method's validated range

None of these settings is exotic. What separates a careful lab from a careless one is whether the conditions are validated for the peptide being tested, applied consistently, and reported.

HPLC system with an autosampler loaded with research vials

An HPLC system. The autosampler injects each sample onto the column, and the detector records the chromatogram used to calculate purity.

What a chromatogram tells you

Feature What it means
Retention time When the main peak left the column. It should be consistent for the same peptide under the same method.
Main-peak area The basis of the purity percentage.
Small peaks before the main peak Usually more hydrophilic impurities, such as some truncated or deletion sequences.
Small peaks after the main peak Usually more hydrophobic impurities, such as sequences with leftover protecting groups.
Shoulders or a broad main peak A possible co-eluting impurity hidden under the main peak.
Flat, quiet baseline Good separation with little background noise.

How mass spectrometry works

A mass spectrometer measures the mass-to-charge ratio (m/z) of ions. To do that it has to turn the peptide into a gas-phase ion, separate ions by m/z, and count them.

Getting peptides into the instrument

Two soft ionization techniques made mass spectrometry of peptides and proteins routine. The 2002 Nobel Prize in Chemistry honored this field, including electrospray:

  • Electrospray ionization (ESI). The liquid sample is sprayed through a charged needle into a fine mist. As droplets evaporate, peptides are left carrying one or more extra protons. ESI works directly on the liquid flowing out of an HPLC column, which is why it is the basis of LC-MS [3].
  • Matrix-assisted laser desorption/ionization (MALDI). The peptide is mixed with a light-absorbing matrix, dried on a plate and hit with a laser pulse. MALDI mostly produces singly charged ions and is often paired with a time-of-flight (TOF) analyzer [4].

Reading the spectrum

Because ESI can add several protons, one peptide appears at several m/z values. For a 1,418.70 Da peptide, the singly protonated ion [M+H]⁺ appears near m/z 1419.71 and the doubly protonated ion [M+2H]²⁺ near m/z 710.36. Software deconvolutes those charge states back into a single neutral mass.

Every ion also shows a small isotope cluster, because a fraction of the carbon atoms in any molecule are carbon-13 rather than carbon-12. That leads to two different "masses" for the same molecule:

Mass type Definition BPC-157 (GEPPPGKPADDAGLV)
Monoisotopic mass Uses the most abundant isotope of each element ≈ 1418.70 Da
Average mass (molecular weight) Weighted by natural isotope abundance ≈ 1419.55 g/mol
[M+H]⁺ Singly protonated ion, common in MALDI m/z ≈ 1419.71
[M+2H]²⁺ Doubly protonated ion, common in ESI m/z ≈ 710.36

When a COA states an identity result, it should compare the measured mass with the theoretical mass for the expected sequence. High-resolution analyzers such as Orbitrap and modern TOF instruments measure mass to within a few parts per million, which makes accidental matches very unlikely.

Confirming the sequence with tandem MS

A matching total mass confirms composition, but not order. Two peptides containing the same amino acids in a different order have the same mass. Tandem mass spectrometry (MS/MS) solves this by selecting the peptide ion, breaking it into fragments, and measuring those fragments. Peptides tend to break along the backbone, producing ladders of fragment ions whose spacing spells out the sequence [5].

Diagram comparing an HPLC chromatogram, which measures purity, with a mass spectrum, which confirms identity

Figure 1. The same sample seen two ways. HPLC measures how much of the material is the main peak; mass spectrometry confirms that the main component has the right mass. Illustrative data modeled on BPC-157.

Head-to-head: HPLC vs mass spectrometry

RP-HPLC (UV) Mass spectrometry
Main question What percentage of the sample is the target? Is the molecule the expected one?
What it measures UV absorbance over time Mass-to-charge ratio of ions
Output Chromatogram; area % purity Mass spectrum; measured mass
Quantitative? Yes, broadly proportional to peptide amount Not inherently; ionization efficiency varies
Confirms identity? No Yes
Separates same-mass isomers? Often, if they differ in hydrophobicity No, not by mass alone
Sees water, salts, counter-ions? No Generally not reported
Typical COA line Purity ≥ 98.0%: 99.23% Identity: Conforms (LC-MS)

What HPLC cannot tell you

HPLC is the right tool for purity, but it has blind spots:

  • It cannot confirm identity. The main peak is simply the biggest peak. If the synthesis produced the wrong peptide cleanly, the purity number can still be high. Independent re-testing has found research peptides where the main compound had a different structure from the one ordered, even though supplier reports showed acceptable purity [13].
  • Co-eluting impurities can hide. An impurity with nearly the same hydrophobicity can sit under the main peak and inflate the purity value. Peak-purity checks using diode-array spectra or mass spectra across the peak were developed precisely to catch this [8].
  • It does not see non-peptide mass. Water, inorganic salts and counter-ions such as trifluoroacetate or acetate do not absorb meaningfully at 214 nm. That is why a lot can be 99% pure while the actual peptide content is a few percent below the label weight.
  • Area percent assumes similar responses. Area normalization works well because related impurities share the same peptide backbone, but impurities with very different structures can absorb more or less strongly than the target.

What mass spectrometry cannot tell you

Mass spectrometry is the right tool for identity, but it has its own blind spots:

  • Same-mass isomers look identical. Leucine and isoleucine have exactly the same mass, as do D- and L-forms of any amino acid. Distinguishing leucine from isoleucine requires specialized fragmentation and high-resolution tandem MS, an active research area in its own right [9]. Racemized residues, a known synthesis impurity, are usually caught by chromatography instead, because the resulting diastereomers often elute at a different time [12].
  • It is not a purity measurement on its own. Different molecules ionize with different efficiency, and some suppress the signal of others, so peak heights in a mass spectrum do not reliably reflect amounts.
  • Mobile-phase choice matters. The same TFA that sharpens HPLC peaks suppresses the electrospray signal. Methods built for LC-MS often switch to formic acid or other modifiers, or add components that counteract the suppression [6, 7]. This is one reason purity and identity are frequently run as separate methods.
Tip

A COA that reports "Identity: Conforms" is stronger when it also shows the measured mass and the theoretical mass side by side. "Conforms" with no numbers behind it is harder to check.

Why the best reports use both: LC-MS and orthogonal methods

Because each method covers the other's blind spots, analytical labs combine them. In LC-MS, the HPLC separates the sample and the mass spectrometer identifies what is in each peak. That lets an analyst assign an identity not only to the main peak but to the impurities around it.

Regulated peptide work takes this further with orthogonal methods: separations based on different principles applied to the same sample. A recent study of the peptide bivalirudin, for example, developed three orthogonal chromatographic methods and then characterized the degradation products with high-resolution mass spectrometry [11]. Another used LC-HRMS to compare the structurally related impurity profiles of teriparatide made by chemical synthesis with teriparatide made by recombinant DNA technology [10].

For approved synthetic peptide drugs, FDA guidance expects peptide-related impurities at 0.10% of the drug substance or above to be identified, and limits any new specified impurity to 0.5% [14]. Research materials are not held to drug standards, but that benchmark shows how seriously individual impurities are treated when the stakes are highest, and why mass spectrometry, the tool that identifies them, sits beside HPLC in serious quality control.

Common peptide impurities and how each method catches them

Solid-phase peptide synthesis and storage produce a predictable family of related impurities [12]. Each one has a signature that one or both methods can detect:

Impurity type What happened Mass shift vs target Usually caught by
Deletion sequence One amino acid failed to couple Minus that residue (e.g. −97.05 Da for proline) MS; often HPLC
Insertion sequence An amino acid coupled twice Plus that residue MS; often HPLC
Truncated chain Synthesis stopped early Large loss HPLC and MS
Incomplete deprotection A protecting group was left on Plus the group (e.g. +56 Da for t-butyl) HPLC (later peak) and MS
Oxidation Methionine or tryptophan oxidized +16 Da per oxygen MS; sometimes HPLC
Deamidation Asparagine or glutamine converted +0.98 Da High-resolution MS; HPLC
Racemization An L-residue became D 0 Da HPLC only (diastereomer)
Counter-ion (TFA, acetate) Salt form from purification Not part of the peptide Neither; tested separately

To make this concrete: if BPC-157 (monoisotopic mass ≈ 1418.70 Da) lost one proline during synthesis, the deletion impurity would appear at about 1321.65 Da, nearly 100 Da lighter and easy for a mass spectrometer to flag. A racemized residue, by contrast, would weigh exactly the same, and only chromatography would separate it.

Other ways labs measure how much peptide is present

Purity and identity do not tell you how many milligrams of peptide are actually in a vial. A lyophilized powder also holds residual water and counter-ions, so labs use separate techniques to measure peptide content:

Technique How it works What it reports
Quantitative HPLC Compares the sample's main-peak area with a reference standard of known concentration mg of peptide, often shown as potency or assay
Amino acid analysis Breaks the peptide into its amino acids by hydrolysis and measures each one Net peptide content as a % of the powder
Nitrogen (CHN) analysis Measures total nitrogen and calculates peptide from the sequence's nitrogen share Net peptide content
Ion chromatography Separates and measures counter-ions such as trifluoroacetate, acetate or chloride Counter-ion content
Karl Fischer titration Reacts with water in the sample Water content

These results explain the gap between purity and label weight. A lot can be 99% pure by HPLC while the powder is, for example, 80–90% peptide by weight, with the rest made up of water and counter-ions. Both numbers are correct; they answer different questions.

Why two labs can report different purity for the same lot

Purity is a measured value, not a fixed property printed on the molecule, so the same material can give slightly different numbers in different hands. Common reasons include:

  • Different gradients or columns. A steeper gradient can merge an impurity into the main peak; a shallower one can separate it. The first lab may report higher purity simply because it resolved less.
  • Different detection wavelengths. Impurities that absorb differently from the target change their share of total area as the wavelength changes.
  • Integration rules. How a lab draws the baseline and where it sets the threshold for counting a small peak both affect the final percentage.
  • Sample age and handling. A peptide that has oxidized or degraded between two tests will show more impurity in the second.
  • Different questions. One lab may report HPLC area purity while another reports content against a standard. The numbers are not comparable.

This is why a single purity figure means most when it comes with its method, its specification and its chromatogram, and why independent re-testing, the kind that found large gaps between supplier certificates and measured purity [13], focuses on the method as much as the result.

How a lab validates these methods

A purity or identity result is only as reliable as the method behind it. The ICH Q2(R2) guideline, adopted by the FDA, sets out how analytical procedures are validated [15]. The characteristics most relevant to peptide testing are:

Validation characteristic What it shows
Specificity The method can distinguish the target from impurities and other components.
Accuracy Results agree with the true value.
Precision Repeated measurements agree with each other.
Range and linearity Results are reliable across the concentrations tested.
Detection and quantitation limits The smallest amount of impurity that can be detected and measured.

When a COA names a method, such as "RP-HPLC" or "LC-MS", it is pointing to a validated procedure. A bare number with no method behind it gives you nothing to evaluate.

How to read the HPLC and MS lines on a COA

When you have a peptide certificate of analysis in front of you, check the analytical lines in this order:

  1. Lot number. It must match the vial. Every result below it describes only that lot.
  2. Identity method and result. Look for LC-MS, ESI-MS or MALDI-TOF, ideally with the measured mass shown beside the theoretical mass.
  3. Purity method and result. Look for RP-HPLC with a specification (for example ≥ 98.0%) and the measured value.
  4. The chromatogram or peak table. It should show one dominant peak, a stable baseline and a total that matches the reported purity.
  5. Potency or net peptide content. This is the amount, not the ratio, and is often slightly below the label for the reasons above.
  6. The laboratory. It should be named and contactable, with a report ID that can be verified.
What you see on the COA Stronger Weaker
Identity "LC-MS: 1418.7 Da observed vs 1418.7 Da theoretical" "Identity: OK" with no method
Purity "RP-HPLC, 214 nm: 99.23% (spec ≥ 98.0%)" "Purity: 99%+" with no method
Evidence Chromatogram and mass spectrum attached Number only
Source Independent lab, report ID, lot match Supplier template, no lot number

What these tests do not tell you

HPLC and mass spectrometry describe the chemical composition of a material at the time it was tested. They do not describe how a compound behaves in any biological system, establish safety or effectiveness for any purpose, or account for what happens to a vial after it leaves the lab. Research compounds are not approved by the FDA for human or veterinary use.

How Codex Research reports these results

Where a lot's results have been reported, the Codex Research COA shows purity by RP-HPLC for that specific lot against a 98.0% specification, and full reports add identity by LC-MS, potency, endotoxin, sterility and microbial results, with the testing laboratory and report ID. You can match the lot number on any product page to the vial before purchase. For how to verify a full report with the lab that issued it, read our guide on third-party testing. For how the two methods apply to specific compounds, see BPC-157 vs TB-500, where about 530 Da separates the two masses, and Glow vs Klow, where one HPLC run has to resolve up to four peptides. If you need the certificate for a specific lot, contact info@codexresearch.shop.

Frequently asked questions

What is the difference between HPLC and mass spectrometry for peptides?
HPLC separates the components of a sample and measures how much of the detected material is the main peptide, which gives a purity percentage. Mass spectrometry measures the molecular mass of the components, which confirms whether the main peptide is the expected molecule. HPLC answers how pure; mass spectrometry answers what it is.
Which is better for testing peptide purity, HPLC or mass spec?
For purity, reversed-phase HPLC with UV detection is the standard method because its response is broadly proportional to the amount of peptide present. Mass spectrometry is the standard for identity. They are complementary rather than competing, and a credible certificate of analysis reports both.
What does LC-MS mean on a COA?
LC-MS means liquid chromatography coupled to mass spectrometry. The sample is first separated by chromatography, then each component flows into the mass spectrometer, which measures its mass. On a peptide COA it is usually the identity test.
Can a peptide pass HPLC and still be the wrong compound?
Yes. HPLC measures how much of the material sits in the main peak, not what that peak is. A different peptide, or a sequence with a substitution, can produce a single clean peak and a high purity number. That is why identity must be confirmed separately by mass spectrometry.
Why is HPLC purity measured at 214 or 220 nm?
The peptide bond itself absorbs ultraviolet light strongly between about 210 and 220 nm. Detecting at that wavelength means almost every peptide component, including impurities, gives a signal, so the main peak can be compared with everything else in the sample.
What is the difference between monoisotopic and average mass?
Monoisotopic mass uses the most common isotope of each element and is what high-resolution instruments resolve as the first peak of an isotope pattern. Average mass is weighted by natural isotope abundance and is what a molecular weight on a label usually refers to. For BPC-157 they are about 1418.70 and 1419.55 Da.
Why does a mass spectrum show more than one peak for one peptide?
Electrospray ionization adds different numbers of protons to the same molecule, so one peptide can appear at several mass-to-charge values. Natural isotopes also create a small cluster of peaks for every ion. Software combines these signals back into the neutral mass of the molecule.
What impurities can mass spectrometry detect?
Mass spectrometry is good at spotting impurities whose mass differs from the target, such as deletion sequences missing an amino acid, insertion sequences, truncated chains, oxidation, deamidation and leftover protecting groups. Each shows up at a predictable mass shift from the main peptide.
What can mass spectrometry not detect?
It cannot separate molecules with exactly the same mass, such as leucine and isoleucine, or D- and L-forms of an amino acid. It is also not inherently quantitative, because different molecules ionize with different efficiency, so it is not used on its own to state a purity percentage.
What can HPLC not detect?
Standard UV-detected HPLC does not see water, inorganic salts or most counter-ions, and it can miss an impurity that elutes at the same time as the main peptide. It also cannot confirm what the main peak is. Those limits are why peptide content and identity are tested separately.
What is a chromatogram?
A chromatogram is the trace an HPLC detector records over time. Each component of the sample appears as a peak at the time it leaves the column. The area under each peak is used to calculate purity, and a good COA includes the chromatogram or a peak table so the result can be checked.
Why does TFA matter in peptide testing?
Trifluoroacetic acid is added to HPLC mobile phases because it sharpens peptide peaks. It also suppresses the signal in electrospray mass spectrometry, so LC-MS methods often use formic acid or other modifiers instead. Peptides purified with TFA are also commonly supplied as TFA salts.
What is tandem mass spectrometry (MS/MS)?
Tandem mass spectrometry selects one ion, breaks it into fragments and measures the fragments. Because peptides break mostly along the backbone, the fragment masses reveal the amino acid order. It confirms the sequence, not just the total mass.
What is an orthogonal method?
An orthogonal method measures the same sample using a different separation or detection principle. Pairing reversed-phase HPLC with mass spectrometry, or with a second chromatography mode, reduces the chance that an impurity hidden by one method goes unnoticed.
How do I check the HPLC and MS results on a COA?
Confirm the lot number matches your vial, then look for the named method beside each result, a chromatogram or peak table for purity, a measured mass compared with the theoretical mass for identity, and the testing laboratory with a report ID that can be verified.

References

  1. Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3-55.
  2. Mant CT, Kovacs JM, Kim HM, et al. Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversed-phase HPLC of model peptides. Biopolymers. 2009;92(6):573-595.
  3. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71.
  4. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 1988;60(20):2299-2301.
  5. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198-207.
  6. Mao Y, Kleinberg A, Zhao Y, et al. Simple addition of glycine in trifluoroacetic acid-containing mobile phases enhances the sensitivity of electrospray ionization mass spectrometry for biopharmaceutical characterization. Anal Chem. 2020;92(13):8691-8696.
  7. Johnson D, Boyes B, Orlando R. The use of ammonium formate as a mobile-phase modifier for LC-MS/MS analysis of tryptic digests. J Biomol Tech. 2013;24(4):187-197.
  8. Lincoln D, Fell AF, Anderson NH, England D. Assessment of chromatographic peak purity of drugs by multivariate analysis of diode-array and mass spectrometric data. J Pharm Biomed Anal. 1992;10(10-12):837-844.
  9. Wu P, Zhang T, Wang G, et al. Direct characterization of leucine and isoleucine residues in peptides using high-resolution tandem mass spectrometry. Anal Chem. 2026;98(28):20912-20925.
  10. Wu P, Cheng Y, Li D, et al. Comparison of structurally related impurity profiles in teriparatide from synthetic and recombinant DNA origin using liquid chromatography-high resolution mass spectrometry. Rapid Commun Mass Spectrom. 2026;40(17):e70125.
  11. Vukoja A, Pavić E, Galović S, et al. Comprehensive analysis of peptide pharmaceutical: development of three orthogonal chromatographic methods and characterization of bivalirudin degradation products by high-resolution mass spectrometry. J Pharm Biomed Anal. 2027;283:117761.
  12. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30.
  13. Verbeke F, Wynendaele E, Braet S, D’Hondt M, De Spiegeleer B. Quality evaluation of synthetic quorum sensing peptides used in R&D. J Pharm Anal. 2015;5(3):169-181.
  14. U.S. FDA. ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin. Guidance for Industry, May 2021.
  15. U.S. FDA / ICH. Q2(R2) Validation of Analytical Procedures. Guidance for Industry, March 2024.
For research use only. This article summarizes published laboratory and preclinical literature for reference. It is not medical advice. Codex Research products are not FDA approved and are not for human or animal consumption or for any clinical or medical use.

Shop the lab

Popular research peptides

BPC-157Repair

Research peptide

BPC-157

Tissue-Repair Research

BPC-157 is a 15-amino-acid synthetic peptide taken from a gastric-juice protein, studied in endothelial, fibroblast and growth-factor research. Lot-tested by HPLC and LC-MS.

99%+Purity+149Reward pts
$59.99
View product
TB-500Repair

Research peptide

TB-500

Tissue-Repair Research

TB-500 is Ac-LKKTETQ, the acetylated actin-binding fragment of Thymosin Beta-4 (residues 17–23), supplied as a lyophilized peptide for actin-regulation and cell-migration research.

99%+Purity+187Reward pts
$74.99
View product
GHK-CuDermal

Research peptide

GHK-Cu

Dermal Matrix Research

GHK-Cu is the copper(II) complex of the tripeptide Gly-His-Lys, a constituent of human plasma, studied in fibroblast matrix and copper-transport research. Lot-tested by HPLC.

99%+Purity+99Reward pts
$39.99
View product
GlowBlends

Research peptide

Glow

Repair Blend

Glow is a three-peptide research blend: 49.87 mg GHK-Cu, 9.88 mg BPC-157 and 9.32 mg TB-500 per vial on the current lot, measured by HPLC and tested on a full safety panel.

99%+Purity+237Reward pts
$94.99
View product
NAD+Cellular

Research peptide

NAD+

Cellular Research

NAD+ is nicotinamide adenine dinucleotide, the oxidized redox coenzyme and sirtuin substrate, supplied as lyophilized powder in 500 mg and 1000 mg vials. Lot-tested by LC-MS.

99%+Purity+224Reward pts
$89.99
View product
KlowBlends

Research peptide

Klow

Repair Blend

Klow is a four-peptide research blend: 51.33 mg GHK-Cu, 11.55 mg KPV, 9.32 mg TB-500 and 8.00 mg BPC-157 per vial on the current lot, for multi-pathway laboratory research.

99%+Purity+249Reward pts
$99.99
View product
Melanotan IIDermal

Research peptide

Melanotan II

Melanocortin Research

Melanotan II is a cyclic lactam analog of alpha-MSH that binds the melanocortin receptors, lot-tested at 99.91% purity with a published certificate.

99%+Purity+112Reward pts
$44.99
View product
IpamorelinGH axis

Research peptide

Ipamorelin

GH-Axis Research

Ipamorelin is a five-residue synthetic peptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, studied as a selective agonist at the ghrelin receptor. Lot-tested by RP-HPLC.

99%+Purity+87Reward pts
$34.99
View product
SemaxNeuro

Research peptide

Semax

Neuropeptide Research

Semax is a seven-residue ACTH(4-7) analogue with a Pro-Gly-Pro tail, studied in BDNF, trkB and cholinergic-neuron research. 5 mg and 10 mg vials, lot-tested by LC-MS.

99%+Purity+124Reward pts
$49.99
View product
SelankNeuro

Research peptide

Selank

Neuropeptide Research

Selank is a seven-residue tuftsin analogue, Thr-Lys-Pro-Arg-Pro-Gly-Pro, studied in enkephalinase and neurotransmission gene-expression research. Lot-tested by LC-MS.

99%+Purity+112Reward pts
$44.99
View product

Keep reading

Purity & COAs
November 14, 2026

What a Peptide Certificate of Analysis Can't Tell You

A certificate of analysis reports the tests a lab ran on one sample on one date. This guide sets out eight things the page cannot tell you, from untested properties and method blind spots to storage after the test, and names the document that fills each gap.

Read Article
Purity & COAs
November 14, 2026

Matching a Peptide COA to Your Lot Number: What to Check

A certificate of analysis describes one lot. This guide shows which five fields tie a report to the vial in your hand, what the sample ID and received date mean, when one report can cover more than one vial size, and what to do when the lot numbers differ.

Read Article
Purity & COAs
November 14, 2026

How Are Peptides Made? Solid-Phase Synthesis Step by Step

Most synthetic peptides are built one amino acid at a time on a resin bead, a method called solid-phase peptide synthesis. This guide walks through each step, explains why a fraction of a percent of yield per step decides the quality of the result, shows where impurities come from, and follows the peptide from crude product to finished vial.

Read Article

From lab to your door

Every compound.Every lot, proven.

U.S.-made research vials, shipped with lot-matched, lab-tested COAs you can scan straight off the label.